Could a symptom registry unmask hidden migraine variants?
NCT ID NCT07754266
First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time
Summary
This study is building a large online registry of US adults who experience sinus, ear, dizziness, and headache symptoms, with or without a migraine diagnosis. Participants answer questions about their symptoms, how these affect daily life, and which treatments they have tried. The goal is to better understand the natural history of these symptoms and to help doctors diagnose and treat them more effectively, potentially reducing delays and unnecessary procedures.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- This registry could help doctors recognize atypical migraine patterns earlier, reducing misdiagnosis and unnecessary tests or surgeries.
- What could go wrong
- As an observational registry, it cannot prove cause and effect, and results depend on self-reported data from participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 10,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2023
- Expected to finish
-
Dec 2033
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study is inclusive of all adult Americans experiencing sinus, vestibular auditory, and/or headache symptoms, with and without a diagnosis of migraine.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Resident of the United States of America * Age of Majority (18+ in 47 states and Washington, D.C., 19+ in Alabama and Nebraska, 21+ in Puerto Rico and Mississippi) * Fluent in English OR Spanish. * Experience sinus, vestibular auditory, and/or headache symptoms, with and without diagnosis of migraine. Exclusion Criteria: * Under 18 years of age, under age of Majority. Minors are not the population of interest for the study at this time.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Dizziness are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Association of Migraine Disorders
RECRUITINGNorth Kingstown, Rhode Island, 02852, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Migraines and tension headaches may be hidden companions to multiple sclerosis
- Could your toothpaste be triggering migraines? trial puts it to the test
- Can sleep, neck pain, and fatigue explain Migraine's daily toll?
- Does estrogen rewire the teenage brain and trigger headaches?
- Do Gender-Affirming hormones trigger headaches? thai survey probes the question
- Inner ear clues to childhood balance problems put to the test